These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 17499606)

  • 1. Inflammatory bowel disease: clinical aspects and established and evolving therapies.
    Baumgart DC; Sandborn WJ
    Lancet; 2007 May; 369(9573):1641-57. PubMed ID: 17499606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcerative colitis.
    Ordás I; Eckmann L; Talamini M; Baumgart DC; Sandborn WJ
    Lancet; 2012 Nov; 380(9853):1606-19. PubMed ID: 22914296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional medical management of inflammatory bowel disease.
    Burger D; Travis S
    Gastroenterology; 2011 May; 140(6):1827-1837.e2. PubMed ID: 21530749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new: innovative concepts in inflammatory bowel disease.
    Sandborn WJ
    Colorectal Dis; 2006 May; 8 Suppl 1():3-9. PubMed ID: 16594957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
    Tsuboi R; Matsumoto S; Miyatani H; Mashima H
    Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
    Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K
    Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine for the treatment of inflammatory bowel disease.
    Criscuoli V; Modesto I; Orlando A; Cottone M
    Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP; Rumiantsev VG
    Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of steroid-resistant inflammatory bowel disease.
    Manz M; Vavricka SR; Wanner R; Lakatos PL; Rogler G; Frei P; Safroneeva E; Schoepfer AM
    Digestion; 2012; 86 Suppl 1():11-5. PubMed ID: 23051721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus inflammatory intestinal diseases in children: ulcerative colitis and Crohn disease. Work Group Academic Medical Center, Amsterdam].
    Büller HA; Maas SM
    Ned Tijdschr Geneeskd; 1996 Mar; 140(10):544-50. PubMed ID: 8628407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.